IMPORTANT SAFETY INFORMATION

Clinical use:

UBRELVY is not authorized for pediatric use.

Contraindications:

Concomitant use with strong CYP3A4 inhibitors.

Relevant warnings and precautions:

Driving and operating machinery

Hypersensitivity reactions

May reduce effectiveness of oral contraceptives

Use in pregnant or breast-feeding women

Dose selection in geriatric patients

For more information:

Consult the Product Monograph for important information regarding adverse reactions, drug interactions and dosing information not discussed in this piece. The Product Monograph is also available by calling us at 1-888-704-8271.

IMPORTANT SAFETY INFORMATION

Clinical use:

UBRELVY is not authorized for pediatric use.

Contraindications:

Concomitant use with strong CYP3A4 inhibitors.

Relevant warnings and precautions:

Driving and operating machinery

Hypersensitivity reactions

May reduce effectiveness of oral contraceptives

Use in pregnant or breast-feeding women

Dose selection in geriatric patients

For more information:

Consult the Product Monograph for important information regarding adverse reactions, drug interactions and dosing information not discussed in this piece. The Product Monograph is also available by calling us at 1-888-704-8271.

IMPORTANT SAFETY INFORMATION

Clinical use:

UBRELVY is not authorized for pediatric use.

Contraindications:

Concomitant use with strong CYP3A4 inhibitors.

Relevant warnings and precautions:

Driving and operating machinery

Hypersensitivity reactions

May reduce effectiveness of oral contraceptives

Use in pregnant or breast-feeding women

Dose selection in geriatric patients

For more information:

Consult the Product Monograph for important information regarding adverse reactions, drug interactions and dosing information not discussed in this piece. The Product Monograph is also available by calling us at
1-888-704-8271.

UBRELVY and its design are trademarks of Allergan Pharmaceuticals International Limited, an AbbVie company, used under license by AbbVie Corporation. 

© 2024 AbbVie. All rights reserved. 

CA-UBR-230004A / JN24  

UBRELVY and its design are trademarks of Allergan Pharmaceuticals International Limited, an AbbVie company, used under license by AbbVie Corporation. 

© 2024 AbbVie. All rights reserved. 

CA-UBR-230004A / JN24